Biotherapeutics startup Hummingbird Bioscience brings its total Series B funding to $25 million
Hummingbird Bioscience, a startup focused on developing new treatments for cancer and other diseases, announced today it has added $6 million to its previously announced Series B, bringing the rounds total to $25 million.
The extension was led by SK Holdings…
Read More
Leave a Reply
Want to join the discussion?Feel free to contribute!